BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27588611)

  • 1. The P-Rex1/Rac signaling pathway as a point of convergence for HER/ErbB receptor and GPCR responses.
    Kazanietz MG; Barrio-Real L; Casado-Medrano V; Baker MJ; Lopez-Haber C
    Small GTPases; 2018 Jul; 9(4):297-303. PubMed ID: 27588611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac signaling in breast cancer: a tale of GEFs and GAPs.
    Wertheimer E; Gutierrez-Uzquiza A; Rosemblit C; Lopez-Haber C; Sosa MS; Kazanietz MG
    Cell Signal; 2012 Feb; 24(2):353-362. PubMed ID: 21893191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer.
    Sosa MS; Lopez-Haber C; Yang C; Wang H; Lemmon MA; Busillo JM; Luo J; Benovic JL; Klein-Szanto A; Yagi H; Gutkind JS; Parsons RE; Kazanietz MG
    Mol Cell; 2010 Dec; 40(6):877-92. PubMed ID: 21172654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis.
    Qin J; Xie Y; Wang B; Hoshino M; Wolff DW; Zhao J; Scofield MA; Dowd FJ; Lin MF; Tu Y
    Oncogene; 2009 Apr; 28(16):1853-63. PubMed ID: 19305425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-Rex1 directly activates RhoG to regulate GPCR-driven Rac signalling and actin polarity in neutrophils.
    Damoulakis G; Gambardella L; Rossman KL; Lawson CD; Anderson KE; Fukui Y; Welch HC; Der CJ; Stephens LR; Hawkins PT
    J Cell Sci; 2014 Jun; 127(Pt 11):2589-600. PubMed ID: 24659802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer.
    Montero JC; Seoane S; Ocaña A; Pandiella A
    Oncogene; 2011 Mar; 30(9):1059-71. PubMed ID: 21042280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells.
    Montero JC; Seoane S; Pandiella A
    Cell Signal; 2013 Nov; 25(11):2281-9. PubMed ID: 23899556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-Rex1 Controls Sphingosine 1-Phosphate Receptor Signalling, Morphology, and Cell-Cycle Progression in Neuronal Cells.
    Hampson E; Tsonou E; Baker MJ; Hornigold DC; Hubbard RE; Massey A; Welch HCE
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-Rex1 regulates neutrophil function.
    Welch HC; Condliffe AM; Milne LJ; Ferguson GJ; Hill K; Webb LM; Okkenhaug K; Coadwell WJ; Andrews SR; Thelen M; Jones GE; Hawkins PT; Stephens LR
    Curr Biol; 2005 Oct; 15(20):1867-73. PubMed ID: 16243035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
    Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
    J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gβγ recruits and activates P-Rex1 via two independent binding interfaces.
    Cervantes-Villagrana RD; Beltrán-Navarro YM; García-Jiménez I; Adame-García SR; Olguín-Olguín A; Reyes-Cruz G; Vázquez-Prado J
    Biochem Biophys Res Commun; 2021 Feb; 539():20-27. PubMed ID: 33412417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a P-Rex1 gene signature in breast cancer cells.
    Barrio-Real L; Wertheimer E; Garg R; Abba MC; Kazanietz MG
    Oncotarget; 2016 Aug; 7(32):51335-51348. PubMed ID: 27351228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.
    Barrio-Real L; Benedetti LG; Engel N; Tu Y; Cho S; Sukumar S; Kazanietz MG
    Breast Cancer Res; 2014 Sep; 16(5):441. PubMed ID: 25248717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer.
    Barrio-Real L; Lopez-Haber C; Casado-Medrano V; Goglia AG; Toettcher JE; Caloca MJ; Kazanietz MG
    Oncotarget; 2018 Jun; 9(47):28612-28624. PubMed ID: 29983884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norbin Stimulates the Catalytic Activity and Plasma Membrane Localization of the Guanine-Nucleotide Exchange Factor P-Rex1.
    Pan D; Barber MA; Hornigold K; Baker MJ; Toth JM; Oxley D; Welch HC
    J Biol Chem; 2016 Mar; 291(12):6359-75. PubMed ID: 26792863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1.
    Lopez-Haber C; Kazanietz MG
    Mol Pharmacol; 2013 May; 83(5):1141-54. PubMed ID: 23478800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.
    Dillon LM; Bean JR; Yang W; Shee K; Symonds LK; Balko JM; McDonald WH; Liu S; Gonzalez-Angulo AM; Mills GB; Arteaga CL; Miller TW
    Oncogene; 2015 Jul; 34(30):3968-76. PubMed ID: 25284585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of a Rac activator,P-Rex1, in neurotrophin-derived signaling and neuronal migration.
    Yoshizawa M; Kawauchi T; Sone M; Nishimura YV; Terao M; Chihama K; Nabeshima Y; Hoshino M
    J Neurosci; 2005 Apr; 25(17):4406-19. PubMed ID: 15858067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via Hypoxia-Inducible Factor 1α.
    Lopez-Haber C; Barrio-Real L; Casado-Medrano V; Kazanietz MG
    Mol Cell Biol; 2016 Aug; 36(15):2011-26. PubMed ID: 27185877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration.
    Hernández-Negrete I; Carretero-Ortega J; Rosenfeldt H; Hernández-García R; Calderón-Salinas JV; Reyes-Cruz G; Gutkind JS; Vázquez-Prado J
    J Biol Chem; 2007 Aug; 282(32):23708-15. PubMed ID: 17565979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.